Position in VCEL
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$25,415,001
-$13,487,761 QoQ
Shares Held
571,252
-52.8% QoQ
Ownership
1.12%
of shares outstanding
% of Portfolio
2.32%
of 13F equity value
Holder Rank
#24
of 317 holders
Holding Since
Mar 2020
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Derivatives in VCEL
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$24,127,500
PutShares
750,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026SG Capital Management LLC holds $25,415,001 across 1 Biotechnology name. VCEL ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VCEL |
Vericel Corp
This page
|
571,252 | $25,415,001 |
All Filings in VCEL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,415,001 | 571,252 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $38,902,762 | 1,209,287 | Shares | Sole | 2026-05-08 | |
| 2026-03-31 | $24,127,500 | 750,000 | Put | Sole | 2026-05-08 | |
| 2023-03-31 | $5,842,479 | 199,266 | Shares | Sole | 2024-06-07 | |
| 2020-03-31 | $1,649,903 | 179,924 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||